Voltaren and Burns second degree - a phase IV clinical study of FDA data

Summary:

Burns second degree is reported as a side effect among people who take Voltaren (diclofenac sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Heparin, and have Back pain.

The phase IV clinical study analyzes which people have Burns second degree when taking Voltaren. It is created by eHealthMe based on reports of 81,356 people who have side effects when taking Voltaren from the FDA, and is updated regularly.

What is Voltaren?

Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.

What is Burns second degree?

Burns second degree is found to be associated with 213 drugs and 351 conditions by eHealthMe. Check the latest studies of Burns second degree.

On Jul, 19, 2026

81,356 people reported to have side effects when taking Voltaren.
Among them, 29 people (0.04%) have Burns second degree.

Could Voltaren cause Burns second degree?

Among these 29 people:

How long have people been on Voltaren when they have Burns second degree? *

What is the gender of people who have Burns second degree when taking Voltaren? *

female: 75.86 %
male: 24.14 %

What is the age of people who have Burns second degree when taking Voltaren? *

What are other drugs people take besides Voltaren? *

What are other side effects people have besides Burns second degree? *

Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 16 people, 55.17%
Fever: 10 people, 34.48%
Rashes (redness): 10 people, 34.48%
Burns Third Degree: 9 people, 31.03%
Skin Exfoliation (removal of the oldest dead skin cells): 8 people, 27.59%
Fall: 7 people, 24.14%
Hypotension (abnormally low blood pressure): 6 people, 20.69%
Oral Mucosa Erosion (erosion of mouth mucous membrane): 6 people, 20.69%
Erythema Multiforme (a type of hypersensitivity reaction): 6 people, 20.69%
Depressed Level Of Consciousness: 6 people, 20.69%

What are the existing conditions these people have? *

Spinal Osteoarthritis (joint cartilage loss in spine): 6 people, 20.69%
Joint Pain: 6 people, 20.69%
Back Pain: 6 people, 20.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.90%
Joint Swelling: 2 people, 6.90%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 2 people, 6.90%
Quit Smoking: 1 person, 3.45%
High Blood Pressure: 1 person, 3.45%
Gait Disturbance: 1 person, 3.45%
Fungal Infection: 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Voltaren and have Burns second degree?

- Check whether Burns second degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Voltaren:

Voltaren (82,346 reports)

Browse all side effects of Voltaren:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Burns second degree:

Burns second degree (213 drugs)

Browse all the conditions that are associated with Burns second degree:

Burns second degree (351 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac sodium (the active ingredients of Voltaren) and Voltaren (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.